What is Carfilzomib used for?

Carfilzomib is an anti-cancer drug acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin.
The U.S. Food and Drug Administration (FDA) approved it on 20 July 2012 for use in patients with multiple myeloma who have received at least two prior therapies, including treatment with bortezomib and an immunomodulatory therapy (such as lenalidomide) and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Source Content : wikipedia

Drugs procurement of Carfilzomib brands in India, sold by Indian Drug Manufacturer. Please call at M: +91 9811747774 or Email Us to know more details about the medicine and its cost price in India.
Carfilzomib

Get In Touch

Carfilzomib suppliers & wholesalers in India

Head Office of Indian Pharma Network (IPN) is in New Delhi, INDIA.
For Indian Patients KYPROLIS (carfilzomib) Injection can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India.
For overseas patient KYPROLIS (carfilzomib) Injection brands in India can be also made available to overseas patients, doctors and hospitals. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Carfilzomib Brands In India

1. KYPROLIS (carfilzomib) Injection

For More Details

Dosage Forms and Strengths

Carfilzomib Biosimilar medicines approved and marketed in India is available as for Single-use vial: 60 mg sterile lyophilized powder.